Abstract:
Objective
To study the clinical effect of phosphocreatine and fructose diphosphate for children with myocarditis.
Methods
A total of 82 children with Myocarditis treated from February 2015 to April 2016 in our hospital were selected.The subjects were randomly divided into two groups,41 cases in each group.The observation group took fructose diphosphate;the control group took phosphocreatine;the treatment lasted for 7-10 d as a course.The clinical effect of the two groups was compared,and level of cTnI,cTnT,LDHI-1 and CK-MB was also observed.
Results
The total effective rate of observation group (92.68%,38/41) was higher than that of control group(65.85%,27/41)(P<0.05).The level of cTnI,cTnT and LDH-1 had no significant difference before treatment between the two groups.After treatment,these levels of observation group were significantly lower than those of control group (P<0.05),but CK-MB level was not statistically different (P>0.05).
Conclusion
Compared with phosphocreatine,fructose diphosphate has a better effect on children with myocarditis,and can improve the children's cardiac function and alleviate inflammation,which is worthy of clinical application.

Key words: Myocarditis, Phosphocreatine, Fructose diphosphate, Child